Joel Greenblatt Ligand Pharmaceuticals Inc Transaction History

Gotham Asset Management, LLC

$9.41 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$49.57 - $72.63 $163,581 - $239,678	-3,300 Reduced 44.1%	4,183 $298,000
Q3 2023 Nov 14, 2023	SELL	$58.86 - $72.67 $105,889 - $130,733	-1,799 Reduced 19.38%	7,483 $448,000
Q2 2023 Aug 14, 2023	BUY	$69.53 - $79.33 $350,222 - $399,585	5,037 Added 118.66%	9,282 $669,000
Q1 2023 May 15, 2023	BUY	$65.67 - $77.08 $278,769 - $327,204	4,245 New	4,245 $312,000
Q3 2022 Nov 14, 2022	BUY	$0.01 - $107.56 $14 - $150,584	1,400 Added 44.54%	4,543 $391,000
Q2 2022 Aug 15, 2022	SELL	$74.52 - $117.06 $107,085 - $168,215	-1,437 Reduced 31.38%	3,143 $280,000
Q1 2022 May 16, 2022	BUY	$94.99 - $151.56 $106,578 - $170,050	1,122 Added 32.45%	4,580 $515,000
Q4 2021 Feb 14, 2022	BUY	$127.69 - $165.85 $134,202 - $174,308	1,051 Added 43.66%	3,458 $534,000
Q3 2021 Nov 15, 2021	SELL	$102.33 - $144.73 $15,861 - $22,433	-155 Reduced 6.05%	2,407 $335,000
Q2 2021 Aug 16, 2021	BUY	$113.03 - $155.64 $59,453 - $81,866	526 Added 25.83%	2,562 $336,000
Q1 2021 May 17, 2021	SELL	$99.52 - $215.83 $167,094 - $362,378	-1,679 Reduced 45.2%	2,036 $310,000
Q4 2020 Feb 16, 2021	BUY	$80.55 - $106.05 $299,243 - $393,975	3,715 New	3,715 $369,000
Q1 2020 May 15, 2020	SELL	$63.37 - $107.88 $156,397 - $266,247	-2,468 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$96.94 - $113.59 $33,250 - $38,961	343 Added 16.14%	2,468 $257,000
Q3 2019 Nov 14, 2019	SELL	$86.25 - $120.16 $5.39 Million - $7.52 Million	-62,546 Reduced 96.71%	2,125 $212,000
Q2 2019 Aug 14, 2019	BUY	$107.38 - $129.34 $4.21 Million - $5.07 Million	39,236 Added 154.26%	64,671 $7.38 Million
Q1 2019 May 15, 2019	BUY	$105.93 - $142.47 $940,446 - $1.26 Million	8,878 Added 53.62%	25,435 $3.2 Million
Q4 2018 Feb 14, 2019	SELL	$128.36 - $272.13 $1.44 Million - $3.06 Million	-11,254 Reduced 40.47%	16,557 $2.25 Million
Q3 2018 Nov 14, 2018	BUY	$211.18 - $274.49 $2.92 Million - $3.79 Million	13,820 Added 98.78%	27,811 $7.63 Million
Q2 2018 Aug 14, 2018	SELL	$150.77 - $207.98 $349,635 - $482,305	-2,319 Reduced 14.22%	13,991 $2.9 Million
Q1 2018 May 15, 2018	SELL	$138.63 - $182.62 $4.96 Million - $6.54 Million	-35,790 Reduced 68.69%	16,310 $2.69 Million
Q4 2017 Feb 14, 2018	BUY	$128.36 - $147.04 $6.69 Million - $7.66 Million	52,100	52,100 $7.13 Million

Others Institutions Holding LGND

# of Institutions

255

Shares Held

18.1M

Call Options Held

26.8K

Put Options Held

9.3K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.82B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track Joel Greenblatt's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.

Account